The promise and pitfalls of long-acting injectable agents for HIV prevention
Raphael J. Landovitz(APLA Health), Marybeth McCauley(Family Health International 360), Ryan Kofron(APLA Health)
Cited by 111
Related Papers
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847